Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2016
Filed with the SEC on Sep 7, 2016 and accepted by EDGAR at Sep 7, 2016, 16:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-05-01 to 2016-07-31 | $1.04bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2015-11-01 to 2016-07-31 | $3.09bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-05-01 to 2016-07-31 | $502.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2015-11-01 to 2016-07-31 | $1.48bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2016-05-01 to 2016-07-31 | $86.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2015-11-01 to 2016-07-31 | $245.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-05-01 to 2016-07-31 | $310.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2015-11-01 to 2016-07-31 | $932.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-05-01 to 2016-07-31 | $146.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-11-01 to 2016-07-31 | $432.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-05-01 to 2016-07-31 | $17.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2015-11-01 to 2016-07-31 | $53.0m | us-gaap:InterestExpense |
| Income tax | 3 months2016-05-01 to 2016-07-31 | $10.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-11-01 to 2016-07-31 | $57.0m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2016-05-01 to 2016-07-31 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2015-11-01 to 2016-07-31 | $1.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-05-01 to 2016-07-31 | $0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2015-11-01 to 2016-07-31 | $1.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-05-01 to 2016-07-31 | 328,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-11-01 to 2016-07-31 | 329,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-11-01 to 2016-07-31 | $559.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2015-11-01 to 2016-07-31 | $87.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2016-05-01 to 2016-07-31 | $37.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2015-11-01 to 2016-07-31 | $112.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2015-11-01 to 2016-07-31 | $388.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-07-31 | $2.20bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-07-31 | $3.53bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-07-31 | $7.73bn | us-gaap:Assets |
| Current liabilities | At period end2016-07-31 | $1.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-07-31 | $3.39bn | us-gaap:Liabilities |
| Long-term debt | At period end2016-07-31 | $1.65bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2016-07-31 | $235.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2016-07-31 | $4.34bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-16-000076. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.